Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;12(2):11410-11422.
doi: 10.1080/21655979.2021.2008738.

Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway

Yong Chen  1 , Dong Wang  1 , Tao Shu  1 , Kangwei Sun  1 , Jianbo Zhao  1 , Min Wang  1 , Yi Huang  1 , Ping Wang  1 , Hang Zheng  1 , Zhixuan Cai  1 , Zengyue Yang  1
Affiliations

Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway

Yong Chen et al. Bioengineered. 2021 Dec.

Abstract

Circular RNAs (circRNAs) play a pivotal regulatory role in bladder cancer (BC) occurrence and progression. The expression level, role and mechanism of circ_0000326 in BC remain unknown. In the present study, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to evaluate the expressions of circ_0000326, microRNA-338-3p (miR-338-3p) and ETS Proto-Oncogene 1(ETS1) mRNA in BC tissues and cell lines. Cell counting kit-8 (CCK-8) assay, wound healing assay and flow cytometry were used to detect the impacts of circ_0000326 on BC cell growth, migration and apoptosis. Western blot was used to detect the expressions of ETS1, phospho-phosphoinositide-3 kinase (p-PI3K), phospho-AKT, PI3K and AKT protein. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to analyze the biological function of ETS1 in BC. Here, we found that circ_0000326 expression was significantly elevated in BC cell lines and tissues, and circ_0000326 could promote BC cell growth and migration, and inhibit apoptosis. Dual-luciferase reporter gene assay confirmed that circ_0000326 and ETS1 could bind directly to miR-338-3p. Furthermore, circ_0000326 sponged miR-338-3p and up-regulated ETS1 expression. ETS1 was associated with the activation of PI3K/AKT pathway. Moreover, circ_0000326 could activate PI3K/AKT pathway by miR-338-3p/ETS1 axis. Collectively, circ_0000326/miR-338-3p/ETS1/PI3K/AKT pathway is involved in regulating BC progression.

Keywords: Circ_0000326; ETS1; PI3K/AKT; bladder cancer; miR-338-3p.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Circ_0000326 expression was significantly up-regulated in BC. (a). The volcano plot of differentially expressed genes (DECs) in GSE92675. The blue and purple dots represented the downregulated DECs and upregulated DECs with statistical significance (log2 |fold change|>2 and P < 0.05), respectively. (b). The heatmap of DECs whose expressions were upregulated in GSE92675.C-D. qRT-PCR showed that circ_0000326 expression was upregulated in BC tissues and cell lines.***P < 0.001
Figure 2.
Figure 2.
Circ_0000326 promoted BC cell proliferation and migration, and inhibited the apoptosis. (a). qRT-PCR showed that linear MALAT1 was degraded by RNase R, while circ_0000326 could not be degraded by RNase R. (b). qRT-PCR showed that circ_0000326 expression was inhibited in BC cells transfected with circ_0000326 siRNAs. (c-d). CCK-8 assay showed that cell proliferation in the si-circ_0000326#1 and si-circ_0000326#3 groups was dramatically suppressed as against the si-NC group. (e). Would healing assay indicated that in comparison to the control group, cell migration capacity in the si-circ_0000326#1 and si-circ_0000326#3 groups was significantly reduced. (f). Flow cytometry showed that the apoptosis rate was significantly increased after circ_0000326 knockdown.*P < 0.05, **P < 0.01 and ***P < 0.001
Figure 3.
Figure 3.
Circ_0000326 could combine with miR-338-3p in BC. (a-b). qRT-PCR indicated that circ_0000326 was mainly distributed in the cytoplasm of 5637 and T24 cell lines. (c). StarBase database was utilized to predict the binding site between circ_0000326 and miR-338-3p. (d). Dual-luciferase reporter assays showed that the luciferase activity of wild-type circ_0000326 reporter was significantly suppressed by miR-338-3p mimics, while the luciferase activity of the mutated reporter was not affected by miR-338-3p mimics. (e). RIP assay showed that circ_0000326 and miR‐338-3p were mainly enriched by anti-Ago2 antibody. (f-g). qRT-PCR showed that miR-338-3p expression was markedly down-regulatedin BC cell lines and tissues. (h). qRT-PCR showed that miR-338-3p expression was significantly increased in BC cells transfected with circ_0000326 siRNA.**P < 0.01 and ***P < 0.001
Figure 4.
Figure 4.
Circ_0000326 could target miR-338-3p to regulate ETS1 expression
Figure 5.
Figure 5.
Circ_0000326 could regulate miR-338-3p/ETS1 to participate in BC progression. (a-b). CCK-8 assay was used to verify the cell proliferation in BC cells transfected with si-circ_0000326, circ_0000326 siRNA and miR-338-3p inhibitor, or circ_0000326 siRNA and ETS1 overexpression plasmid. (c-d). Wound healing assay was used to detect the migration of BC cells transfected with si-circ_0000326, circ_0000326 siRNA and miR-338-3p inhibitor, or circ_0000326 siRNA and ETS1 overexpression plasmid. (e-f). Flow cytometry was used to detect the apoptosis of BC cells transfected with si-circ_0000326, circ_0000326 siRNA and miR-338-3p inhibitor, or circ_0000326 siRNA and ETS1 overexpression plasmid. *P < 0.05, **P < 0.01 and ***P < 0.001
Figure 6.
Figure 6.
Circ_0000326/miR-338-3p/ETS1 activated PI3K/AKT signal pathway in BC
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. - PubMed
    1. Lorenzatti HG, Cates AL, El-Sawy L, et al. A surgical orthotopic approach for studying the invasive progression of human bladder cancer. Nat Protoc. 2019;14:738–755. - PMC - PubMed
    1. Kristensen LS, Hansen TB, Veno MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37:555–565. - PMC - PubMed
    1. Zhang Y, Liang W, Zhang P, et al. Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res. 2017;36:152. - PMC - PubMed
    1. Yu K, Liu M, Huang Y, et al. circMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer. Pathol Res Pract. 2021;14:153613. - PubMed

MeSH terms

Grants and funding

The author(s) reported that there is no funding associated with the work featured in this article.

LinkOut - more resources